Literature DB >> 14614596

Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome.

D Werber1, A Fruth, U Buchholz, R Prager, M H Kramer, A Ammon, H Tschäpe.   

Abstract

The aim of this study was to investigate the association between Shiga toxin-producing Escherichia coli (STEC) O157 and the simultaneous presence of the virulence genes stx2 and eae in STEC from patients with gastroenteritis. In Germany, the proportion of serogroup O157 is substantially higher among STEC isolates from patients with haemolytic uraemic syndrome (HUS) than among STEC isolates from patients with gastroenteritis. The reason for this is unknown. Independent of serogroup, the virulence genes stx2 and eae have been associated with severe disease. Data collected in 2000-2001 from a Germany-wide laboratory-based surveillance system for STEC-associated gastroenteritis in patients <15 years were analysed. Overall, 18% of the STEC isolates belonged to serogroup O157. Compared with non-O157 strains, 0157 isolates were strongly associated with the simultaneous presence of both an stx2 gene and the eae gene (OR, 76; 95%CI, 27-230). Within the subset of STEC isolates that carried both virulence genes, 60% belonged to serogroup O157, a proportion similar to that found in STEC isolates from pediatric patients with HUS in Germany and Austria (67%, P=0.35). These data suggest that the more frequent carriage of both virulence genes, i.e. stx2 and eae, forms the basis of why STEC O157 predominates in patients with HUS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614596     DOI: 10.1007/s10096-003-1025-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  18 in total

1.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.

Authors:  Alexander W Friedrich; Martina Bielaszewska; Wen-Lan Zhang; Matthias Pulz; Thorsten Kuczius; Andrea Ammon; Helge Karch
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

2.  The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings.

Authors:  N Banatvala; P M Griffin; K D Greene; T J Barrett; W F Bibb; J H Green; J G Wells
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

3.  Identification of Escherichia coli O-serogroups by restriction of the amplified O-antigen gene cluster (rfb-RFLP).

Authors:  R S Coimbra; F Grimont; P Lenormand; P Burguière; L Beutin; P A Grimont
Journal:  Res Microbiol       Date:  2000-10       Impact factor: 3.992

4.  Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans.

Authors:  P Boerlin; S A McEwen; F Boerlin-Petzold; J B Wilson; R P Johnson; C L Gyles
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

5.  Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells.

Authors:  C B Louise; T G Obrig
Journal:  J Infect Dis       Date:  1995-11       Impact factor: 5.226

6.  Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.

Authors:  Richard L Siegler; Tom G Obrig; Theodore J Pysher; Vernon L Tesh; Nathaniel D Denkers; Fletcher B Taylor
Journal:  Pediatr Nephrol       Date:  2003-01-10       Impact factor: 3.714

7.  Properties of Vero cytotoxin-producing Escherichia coli of human origin of O serogroups other than O157.

Authors:  G A Willshaw; S M Scotland; H R Smith; B Rowe
Journal:  J Infect Dis       Date:  1992-10       Impact factor: 5.226

8.  Virulence markers of Shiga-like toxin-producing Escherichia coli strains originating from healthy domestic animals of different species.

Authors:  L Beutin; D Geier; S Zimmermann; H Karch
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

9.  Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.

Authors:  Angela Gerber; Helge Karch; Franz Allerberger; Hege M Verweyen; Lothar B Zimmerhackl
Journal:  J Infect Dis       Date:  2002-08-02       Impact factor: 5.226

10.  Prevalence of non-O157:H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska.

Authors:  P D Fey; R S Wickert; M E Rupp; T J Safranek; S H Hinrichs
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883

View more
  27 in total

1.  Seasonal variation of HUS occurrence and VTEC infection in children with acute diarrhoea from Argentina.

Authors:  M A Rivero; J A Passucci; E M Rodríguez; A E Parma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-22       Impact factor: 3.267

2.  Enhanced surveillance of non-O157 verotoxin-producing Escherichia coli in human stool samples from Manitoba.

Authors:  Laura H Thompson; Sandra Giercke; Carole Beaudoin; David Woodward; John L Wylie
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-11       Impact factor: 2.471

3.  Influence of RNase E deficiency on the production of stx2-bearing phages and Shiga toxin in an RNase E-inducible strain of enterohaemorrhagic Escherichia coli (EHEC) O157:H7.

Authors:  Thujitha Thuraisamy; Patricia B Lodato
Journal:  J Med Microbiol       Date:  2018-04-05       Impact factor: 2.472

Review 4.  Glycosphingolipid functions.

Authors:  Clifford A Lingwood
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

5.  Association of nucleotide polymorphisms within the O-antigen gene cluster of Escherichia coli O26, O45, O103, O111, O121, and O145 with serogroups and genetic subtypes.

Authors:  Keri N Norman; Nancy A Strockbine; James L Bono
Journal:  Appl Environ Microbiol       Date:  2012-07-13       Impact factor: 4.792

6.  Identification and characterization of spontaneous deletions within the Sp11-Sp12 prophage region of Escherichia coli O157:H7 Sakai.

Authors:  Chun Chen; Carrie R Lewis; Kakolie Goswami; Elisabeth L Roberts; Chitrita DebRoy; Edward G Dudley
Journal:  Appl Environ Microbiol       Date:  2013-01-11       Impact factor: 4.792

7.  Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle.

Authors:  Diane R Baker; Rodney A Moxley; Mike B Steele; Jeffrey T Lejeune; Jane Christopher-Hennings; Ding-Geng Chen; Philip R Hardwidge; David H Francis
Journal:  Appl Environ Microbiol       Date:  2007-09-21       Impact factor: 4.792

8.  2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.

Authors:  Andi L Shane; Rajal K Mody; John A Crump; Phillip I Tarr; Theodore S Steiner; Karen Kotloff; Joanne M Langley; Christine Wanke; Cirle Alcantara Warren; Allen C Cheng; Joseph Cantey; Larry K Pickering
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079

9.  Shiga toxin-producing Escherichia coli in British Columbia, 2011-2017: Analysis to inform exclusion guidelines.

Authors:  K Noftall; M Taylor; L Hoang; E Galanis
Journal:  Can Commun Dis Rep       Date:  2019-09-05

Review 10.  Therapeutic Uses of Bacterial Subunit Toxins.

Authors:  Clifford Lingwood
Journal:  Toxins (Basel)       Date:  2021-05-26       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.